7 Pharmaceuticals Stocks to Buy Now

7 Pharmaceuticals Stocks to Buy Now

This week, 7 Pharmaceuticals stocks are improving their overall ratings on Portfolio Grader. Each of these stocks is rated an “A” (“strong buy”) or “B” overall (“buy”).

This week, Taro Pharmaceutical Industries Ltd.’s (TARO) ratings are up from a C last week to a B. Taro Pharmaceutical Industries Ltd. is engaged in developing, manufacturing, and marketing prescription and over-the-counter pharmaceutical products, as well as active pharmaceutical ingredients in the United States, Canada and Israel. The company also gets A’s in return on equity and free cash flow. For more information, get Portfolio Grader’s complete analysis of TARO stock.

Merck & Co., Inc. (MRK) gets a higher grade this week, advancing from a C last week to a B. Merck & Co., Inc. is a global health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. For more information, get Portfolio Grader’s complete analysis of MRK stock.

GlaxoSmithKline plc Sponsored ADR (GSK) earns a B this week, jumping up from last week’s grade of C. GlaxoSmithKline plc Sponsored ADR is a research-based pharmaceutical company. The company also gets A’s in return on equity. For more information, get Portfolio Grader’s complete analysis of GSK stock.

This week, Heska Corporation (HSKA) pushes up from a B to a A rating. Heska Corporation discovers, develops, manufactures, and markets companion animal health products, primarily for dogs, cats, and horses. The company also gets A’s in operating margin growth, earnings growth, and earnings revisions. For more information, get Portfolio Grader’s complete analysis of HSKA stock.

Cynapsus Therapeutics Inc. (CYNA) shows solid improvement this week. The company’s rating rises from a C to a B. The company also gets A’s in earnings momentum. For more information, get Portfolio Grader’s complete analysis of CYNA stock.

Teligent, Inc.’s (TLGT) ratings are looking better this week, moving up to a B from last week’s C. The company also gets A’s in sales growth. For more information, get Portfolio Grader’s complete analysis of TLGT stock.

Evoke Pharma, Inc. (EVOK) is seeing ratings go up from a C last week to a B this week. For more information, get Portfolio Grader’s complete analysis of EVOK stock.

Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.


Article printed from InvestorPlace Media, https://investorplace.com/2016/07/7-pharmaceuticals-stocks-to-buy-now-4/.

©2019 InvestorPlace Media, LLC